ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

TSHA Taysha Gene Therapies Inc

2.39
0.05 (2.14%)
May 13 2024 - Closed
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 0002.5M4.71M2.4M4.75M3.6M
Operating Income -49.27M-32.99M-25.07M-18.7M-16.56M-23.38M-15.63M-15.8M
Pre Tax Income -50.11M-33.87M-26.31M-55.72M-17.62M-24.6M-117.09M47.74M
Net Income -50.11M-33.87M-26.31M-55.72M-17.62M-24.6M-117.09M47.74M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -49.28M-32.99M-25.08M-18.71M-16.57M-23.38M-15.65M-15.82M
EBITDA -49.01M-32.71M-24.8M-18.34M-16.23M-23.04M-15.3M-15.43M
Year End December 30 2023 20192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 0002.5M15.45M
Operating Income -1.12M-43M-173.27M-126.03M-71.37M
Pre Tax Income -1.12M-60.01M-174.52M-166.01M-111.57M
Net Income -1.12M-60.01M-174.52M-166.01M-111.57M
Preferred Dividends 00000
Basic Earnings Per Share (EPS) -0.102-1.589-4.536-2.626-0.597
EBIT -1.12M-43M-173.27M-126.05M-71.42M
EBITDA -1.12M-42.99M-172.78M-124.86M-70M

Your Recent History

Delayed Upgrade Clock